Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: Analysis from the treatment approaches in renal cancer global evaluation trial (TARGET)

✍ Scribed by Choueiri, Toni K.; Cheng, Suchun; Qu, Angela Q.; Pastorek, Jaromir; Atkins, Michael B.; Signoretti, Sabina

• Book ID: 123558037
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 353 KB
• Volume: 31
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2012.07.004